Kidron Nadav (CIK 0001351779)

Latest company ownership

Shares held
126,000
Last filed at
Jan 8, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2015Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Mar 16, 2023 Mar 16, 2023 ORAMED PHARMACEUTICALS INC. CEO Buy 82.5 +26,000 2.25% ✗ $53K
Mar 14, 2023 Mar 15, 2023 ORAMED PHARMACEUTICALS INC. CEO Buy 90.0 +100,000 9.50% ✗ $201K
Jul 28, 2022 Aug 1, 2022 ORAMED PHARMACEUTICALS INC. CEO Sell 95.0 +147,369 15.83% ✗ $105.6K
Jan 3, 2022 Jan 11, 2022 ORAMED PHARMACEUTICALS INC. CEO Sell 97.5 +164,248 21.43% ✗ $677.2K
Jan 3, 2022 Jan 5, 2022 ORAMED PHARMACEUTICALS INC. CEO Sell 97.5 +164,248 20.88% ✗ $677.2K
Dec 28, 2021 Dec 30, 2021 ORAMED PHARMACEUTICALS INC. CEO Sell 40.0 -51,728 -6.32% ✗ $411.8K
Aug 9, 2021 Dec 7, 2021 ORAMED PHARMACEUTICALS INC. CEO Sell 10.0 -220,000 -22.96% ✓ $4.4M
Aug 9, 2021 Aug 11, 2021 ORAMED PHARMACEUTICALS INC. CEO Sell 5.0 -220,000 -25.33% ✓ $4.4M
Jul 10, 2018 Jul 12, 2018 ORAMED PHARMACEUTICALS INC. CEO Buy 47.5 +61 0.01% ✗ $357.2
May 12, 2016 May 12, 2016 ORAMED PHARMACEUTICALS INC. CEO Buy 55.0 +1,000 0.10% ✗ $7K
May 12, 2015 May 12, 2015 ORAMED PHARMACEUTICALS INC. CEO Buy 55.0 +600 0.06% ✗ $4K
Mar 18, 2015 Mar 20, 2015 ORAMED PHARMACEUTICALS INC. CEO Buy 61.3 +2,600 0.27% ✗ $10.1K